Amide compounds are disclosed. Also disclosed are pharmaceutical compositions comprising the compounds as well as methods of treating neurodegenerative diseases that involve administering the compounds or pharmaceutical compositions to a subject.

The present invention relates to a process for preparing compounds of the formula (I)

##STR00001##

starting from compounds of the formula (II)

##STR00002##

in which R.sup.1, R.sup.2 and R.sup.3 have the abovementioned meaning and where R.sup.1 and R.sup.3 are not simultaneously hydrogen in any compound.

The invention further provides the compounds of the formulae (IVa), (IVb), (V) and (VI) in which R.sup.1, R.sup.2, R.sup.3, R.sup.5, M and n have the abovementioned meaning.

##STR00003##

The present invention relates to a process for preparing compounds of the formula (I)

##STR00001##

starting from compounds of the formula (II)

##STR00002##

in which R.sup.1, R.sup.2 and R.sup.3 have the abovementioned meaning and where R.sup.1 and R.sup.3 are not simultaneously hydrogen in any compound.

The invention further provides the compounds of the formulae (IVa), (IVb), (V) and (VI) in which R.sup.1, R.sup.2, R.sup.3, R.sup.5, M and n have the abovementioned meaning.

##STR00003##

A linker molecule and method for treating a substrate surface is provided, which includes a linker molecule with a plurality of moieties capable of resisting non-specific binding of proteins whilst permitting specific binding of a target biomolecule or a biomolecule of interest, including antibodies.

A linker molecule and method for treating a substrate surface is provided, which includes a linker molecule with a plurality of moieties capable of resisting non-specific binding of proteins whilst permitting specific binding of a target biomolecule or a biomolecule of interest, including antibodies.

The invention provides a compound of Formula I: ##STR00001##
or a pharmaceutically acceptable salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of Formula I, processes for preparing compounds of Formula I, therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS symptoms in a mammal using compounds of Formula I.

The invention provides a compound of Formula I: ##STR00001##
or a pharmaceutically acceptable salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of Formula I, processes for preparing compounds of Formula I, therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS symptoms in a mammal using compounds of Formula I.

The invention relates to hydrazide compounds and their use in medicine, particularly in treating and/or preventing infections caused by a fungus.

The invention relates to hydrazide compounds and their use in medicine, particularly in treating and/or preventing infections caused by a fungus.

The invention relates to novel hydrazide-based templates, methods of making the same, and methods of using the hydrazide-based templates as molecular scaffolds for asymmetric light driven transformations, light driven material synthesis, and biological applications. Furthermore, the present invention relates to photoinitiators, monomers, and polymers derived from biomass, together with methods and methods of using the same.